Results 211 to 220 of about 990,536 (371)

1359Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide - preliminary results from the strokestop 2 study [PDF]

, 2018
Katrin Kemp Gudmundsdottir, Emma Svennberg, Faris Al‐Khalili, T Fredriksson, Viveka Frykman, Leif Friberg, Mårten Rosenqvist, Johan Engdahl   +7 more
openalex   +1 more source

Prognostic impact of iron deficiency in new‐onset chronic heart failure: Danish Heart Failure Registry insights

ESC Heart Failure, Volume 12, Issue 2, Page 1346-1357, April 2025.
Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl, Tor Biering‐Sørensen, Morten Lock Hansen, Mariam Elmegaard Malik, Nina Nouhravesh, Charlotte Anderrson, Morten Schou, Gunnar Gislason   +12 more
wiley   +1 more source

Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation. [PDF]

Cell Mol Life Sci
Manni G, Barcelos ECS, Ricciuti D, Pieroni B, Gargaro M, Mencarelli G, Acha-Orbea H, Talesa VN, Mezzasoma L, Fallarino F.   +9 more
europepmc   +1 more source

Cord Blood (UCB) and 24 Hours Postnatal (PN-24) Reference Values of B-Type Natriuretic Peptide (BNP) among Elective CS (ECS) Born Healthy Full Term (FT) Neonates [PDF]

, 2011
P Srinivasan, Preeti Jain, Leela Cherian, Myung-Rho Kim, M Brandler, Eric Lavery, E Koenig, Keith Williams   +7 more
openalex   +1 more source

Machine learning to optimize use of natriuretic peptides in the diagnosis of acute heart failure. [PDF]

Eur Heart J Acute Cardiovasc Care
Doudesis D, Lee KK, Anwar M, Singer AJ, Hollander JE, Chenevier-Gobeaux C, Claessens YE, Wussler D, Weil D, Kozhuharov N, Strebel I, Sabti Z, deFilippi C, Seliger S, Mesquita ET, Wiemer JC, Möckel M, Coste J, Jourdain P, Kimiaki K, Yoshimura M, Ibrahim I, Ooi SBS, Kuan WS, Gegenhuber A, Mueller T, Hanon O, Vidal JS, Cameron P, Lam L, Freedman B, Chung T, Collins SP, Lindsell CJ, Newby DE, Japp AG, Shah ASV, Villacorta H, Richards AM, McMurray JJV, Mueller C, Januzzi JL, Mills NL, CoDE-HF investigators .   +43 more
europepmc   +1 more source

Natriuretic Peptides and Need for Reliable Tool to Assess Pulmonary Congestion for Treatment Monitoring in Heart Failure. [PDF]

J Community Hosp Intern Med Perspect, 2023
Bhatia MS, Attri R, Sharda SC, Swarup P, Garg A.   +4 more
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex. [PDF]

JACC Adv
Bobrowski D, Abdel-Qadir H, McNaughton CD, Chu A, Wang X, Austin PC, Doumouras BS, Abdul-Samad K, Kavsak PA, Farkouh ME, Januzzi JL, Ross HJ, Lee DS.   +12 more
europepmc   +1 more source

Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions. [PDF]

Yale J Biol Med, 2023
Samad M, Malempati S, Restini CBA.
europepmc   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source